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Abstract
Background: Many older adults with mobility limitations use assistive technology to help them perform daily activities.
However, little attention has been paid to the impact on their family caregivers. This neglect produces an incomplete
portrayal of the outcomes of assistive technology provision. This paper describes the protocol for a study that examines
the impact of a tailored assistive technology intervention that is inclusive of assistance users and their family caregivers.
Methods/design: This research will use a combination of quantitative and qualitative methods. The quantitative
portion will be an experimental, single-blinded study in which participants are randomly assigned to either an
experimental assistive technology intervention or a standard care group. We will enroll 240 participants (120 dyads)
into the study from three Canadian sites. Participants will include older adults (>55) and family caregivers who provide
≥4 h per week of assistance with daily activities and social participation. The primary outcome measure for the older
adults will be the Functional Autonomy Measurement System, and the primary outcome measure for the caregivers
will be the Caregiver Assistive Technology Outcomes Measure. Qualitative data will be collected through detailed
records of the therapists’ interventions, as well as through interviews with dyads and therapists following the
interventions. Data collection will occur at baseline (T0) with follow-ups at 6 weeks (T1), 22 weeks (T2), and 58 weeks (T3)
after baseline evaluation.
Discussion: The findings from this study will help service providers and clinicians to move forward with assistive
technology recommendations that are more attuned to the needs of both older adults with mobility limitations
and their family caregivers. Additionally, the study’s findings will enhance our conceptual understanding of the
spectrum of assistive technology outcomes and set the stage for econometric studies assessing cost-effectiveness.
Trial registration: ClinicalTrials.gov Identifier: NCT01640470. Registered 11/21/2011.
Keywords: Randomized control trial, Older adults, Assistive technology, Informal caregiving
* Correspondence: louise.demers@umontreal.ca
1Centre de recherche de l’Institut universitaire de gériatrie de Montréal,
Centre intégré universitaire de santé et de services sociaux du
Centre-Sud-de-l’Île-de-Montréal, Montréal, PQ, Canada
2École de réadaptation, Université de Montréal, Montréal, PQ, Canada
Full list of author information is available at the end of the article
© 2016 Demers et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Demers et al. BMC Geriatrics  (2016) 16:103 
DOI 10.1186/s12877-016-0269-3
Background
With the aging population, there is an unprecedented
growth of community-dwelling older adults experiencing
physical disabilities and limitations of their mobility [1].
Assistive technology (AT) can play an important role in
facilitating daily activities and social participation for
these individuals [2]. Most commonly adopted AT in-
clude mobility-related items such canes, walkers, and
wheelchairs, and environmental modifications such as
grab bars, raised toilet seats, and bath seats [3, 4]. The
use of these devices increases with age, ranging from
14–18 % in a healthy senior population [3] to 45–96 %
in frail older adults [5, 6]. Notwithstanding this trend,
large numbers of unmet AT needs have been reported in
the ageing population [7, 8].
High quality evidence regarding the benefits of AT for
older individuals is rare. One example is the randomized
control trial (RCT) by Gitlin and colleagues [9]. This
study found that the use of AT is associated with long-
term positive outcomes with daily tasks, greater self-
efficacy, less fear of falling, fewer home hazards, and
greater use of adaptive strategies. Despite the potential
benefits, adoption of AT by older adults is challenging.
Common barriers include limited information about AT
use and availability, its cost, and its incompatibility with
users’ physical environment [10]. Another concern is
the proportion of individuals who discontinue using the
devices [11, 12]. To increase the acceptance and adher-
ence to its optimal usage, greater attention to users’
and caregivers’ goals and preferences has been recom-
mended [13, 14].
Insights on AT outcomes for older adults should also
include consideration of the caregivers that provide
them support. Indeed, a major goal for providing AT to
older adults is that it decreases reliance on personal as-
sistance or even replaces it [15–17]. In practice, both AT
and human assistance are used by a majority of older
people [16, 18–20]. This study is concerned with family
caregivers, defined as individuals who provide unpaid as-
sistance to individuals with disabilities [21, 22]. Family
caregivers of older adults are frequently either spouses
or adult children. In attempting to maintain or enhance
the quality of life of those they help, those caregivers
may experience a great deal of stress that can lead to
their physical or emotional burnout [23]. The potential
for burnout poses a challenge to the health care system,
as family caregivers provide their unfunded assistance
four times more frequently than formal caregivers [24–
26]. This value excludes loss of economic productivity
associated with time spent providing care, and emotional
and physical burden [27].
Two conceptual models contribute to understanding
the relationship between AT interventions and outcomes
for family caregivers. The first model [28, 29] describes
how assistance users’ personal strategies, which fre-
quently include the use of AT, affect them and their fam-
ily caregivers. Specifically, AT influences the manner and
the extent of concerted human help required with activ-
ities. In some cases, a very successful outcome with AT
may wholly eliminate the need for caregiver assistance,
in terms of physical and psychological demands. The
second model [30] demonstrates how AT can alter care-
givers’ stressors so that their participation, health, and
quality of life can be improved. The impact of AT varies
with the type of device and the amount and manner in
which it is used. The use of AT modulates the relation-
ship among characteristics of primary stressors (e.g.,
areas of assistance, effort and safety), the features of sec-
ondary stressors (e.g., role overload and elective use of
time), and broader caregiver outcomes (e.g., health and
social participation).
Despite existing theory, little attention has been given
to the impact of AT use on family caregivers in experi-
mental studies. Mortenson and colleagues [17] con-
ducted a systematic review suggesting that AT use
reduces the degree of physical and emotional effort re-
quired when supporting an individual with a disability.
However, the studies reviewed were primarily descriptive
using cross-sectional data, undermining the strength of
the inference. Additionally, the impact of AT use on
caregivers was inferred from responses to very few quer-
ies, principally dealing with the number of hours of as-
sistance provided. Marasinghe [16] reviewed existing
findings to examine whether and how AT reduces care-
giver burden. She found that AT contributes to reducing
caregiver burden but that AT limitations can also add to
their burden. In a previous study, our group [31] con-
duced a delayed intervention RCT with 44 dyads con-
sisting of community-dwelling older adults and their
family caregivers. It was the first experimental study to
demonstrate that the provision of AT, embedded in an
individually tailored approach, decreases caregiver bur-
den and increases independence for older adults. The
design did not, however, provide a parallel comparison
group to assess the extent to which the intervention was
superior to customary care and, thus, how it actually
worked in real life. The findings from this RCT will re-
spond to this gap and also aid in understanding the ef-
fectiveness of AT on improving older adults’ functional
performance.
Study goal and hypotheses
This RCT will examine whether a home-based, individu-
ally tailored approach to AT provision can improve older
adults’ independence and decrease their family care-
givers’ perceived burden compared to customary care.
We expect that older adults randomized to the experi-
mental condition will have higher activity performance
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following the novel intervention than those assigned to
customary care, and that family caregivers will report
significantly reduced burden in their caregiver activities.
Hypothesis 1: Compared to AT users in the customary
care group, AT users in the experimental group will per-
form daily activities more independently after comple-
tion of the intervention. Secondarily, AT users in the
experimental group will also perform instrumental activ-
ities of daily living more independently following the
intervention.
Hypothesis 2: Following the intervention, family care-
givers in the experimental group will report a signifi-
cantly reduced frequency of physical and psychological
demands associated with problematic caregiving activ-
ities, compared with caregivers in the customary care
group. Secondarily, family caregivers in the experimental
group will experience a decrease in their overall per-
ceived burden following the intervention.
Methods/design
The overall study will be based on a randomized con-
trolled experimental design. However, a combination of
qualitative and quantitative methods and measures will
be used. The advantage of using mixed methods is that
they provide multiple perspectives on an intervention’s
outcomes so they can be understood more completely
[32]. Multiple views also afford the opportunity for data
triangulation, thus increasing the credibility of the find-
ings. Throughout the course of administering the inter-
vention, the therapists carrying out the experimental
approach will record their impressions about both the
successful and unsuccessful aspects of the intervention.
A purposeful sample of dyads from both groups will be
interviewed about their experiences after completing the
intervention and at the conclusion of the study. Any
changes to the protocol will be made through the trial
registry. The anticipated end date of the study will be
March 31, 2017.
Quantitative study design
This study protocol follows CONSORT guidelines. A
single blind RCT will be conducted with 120 dyads, each
consisting of an older AT user and his or her principal
family caregiver. Both the experimental and customary
care interventions will be provided to participants after
the administration of the outcome measures at baseline.
The measures will be re-administered to both groups
6 weeks, 22 weeks (the main trial endpoint), and
58 weeks after baseline evaluation. Figure 1 depicts the
study design.
Participants
Participants will be recruited from three sites in Canada:
Montreal, Ottawa and Vancouver. To be eligible for the
study, a dyad must consist of one assistance user and a
one family caregiver. Assistance users must be (a) age
55 years or older, (b) living at home, (c) have a mobility
limitation qualifying them for referral for homecare ser-
vices, and (d) needing assistance with daily activities or
social participation for a total of 4 h or more per week.
Users may include individuals who currently are not
using AT or are experiencing problems with their
current devices. The population of interest is based off
the amount of assistance received rather than on the
diagnosis, because the use of AT is not diagnosis specific
and there can be great heterogeneity among individuals
with specific diagnoses. The family caregiver must be (a)
age 18 years or older, and (b) delivering unpaid assist-
ance with daily activities or social participation for a
total of 4 h or more per week for at least 1 month. It is
not required that assistance users and family caregivers
reside together.
Dyads will be excluded if either member has a degree
of cognitive impairment likely to prevent her or him
from reliably completing the study questionnaires or if
either has an advanced terminal illness. Cognitive status
will be measured with the Montreal Cognitive Assess-
ment (MoCA), a cognitive screening test designed to be
sensitive to mild deficits. It has good test-retest reliabil-
ity (correlation coefficient = .92) and internal consistency
(Cronbach α = .83) [33].
Recruitment
Participating dyads will be either existing clients or clients
who have been recently referred to home care for occupa-
tional therapy services at the Montreal, Ottawa and
Vancouver sites. Montreal participants will be recruited
through the West Island Health and Social Services Cen-
ter, Ottawa participants through the Community Care Ac-
cess Centers, and Vancouver participants through the









Baseline data collection (T0) Baseline data collection (T0)
Data collection (T1) Data collection (T1)
ATPUT Intervention Customary care
Data collection (T2) Data collection (T2)
Data collection (T3) Data collection (T3)
Fig. 1 ATPUT, Assistive Technology Provision, Updating and
Tune-Up intervention
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identified and recruited via referral lists and initially
screened by home-care staff to ensure eligibility criteria
are met. The sites’ study coordinators will then contact all
interested individuals to confirm their eligibility, fully ex-
plain the project, answer questions, and obtain consent.
Study participants will be permitted to withdraw from the
intervention at any time they desire or if they become too
ill. Due to ethical constraints the investigators cannot
compel those who withdraw to provide further data. If the
participant voluntarily discloses the reason for withdrawal,
these will be documented.
Randomization and blinding
Study coordinators at each site will randomly assign par-
ticipants into the experimental group or control group
immediately following their recruitment. The experi-
mental group will consist of dyads that receive the
home-based AT Provision, Updating and Tune-Up
(ATPUT) intervention. Control group dyads will receive
the customary care prevailing at the site where they were
recruited. Centralized randomization software will be
used to obtain the same number of participants in each
group (www.randomization.com). Participating dyads
will be blinded regarding their group assignment to the
extent that they will be unfamiliar with the intervention
received by the other group. Raters administering the
outcome measures will be blinded until completion of
the trial. Owing to the nature of the intervention, how-
ever, it is unfeasible to blind the study coordinators or
the occupational therapists providing the intervention.
Customary intervention
Current AT interventions in Canada take place in the
community and are provided by registered occupational
therapists. According to collaborators at the participat-
ing sites, customary interventions are not standardized.
For example, family caregivers are not required to be in-
cluded within the intervention process. Individuals are
provided with equipment based on local funding policies
and have limited practice time with devices. Follow-up
visits are at the discretion of the therapists. Participants
in the control group will receive services provided to cli-
ents by the health authorities within the study, with no
additional intervention from the study.
Experimental intervention
The experimental intervention will involve a detailed in-
home assessment of the older adult’s current AT as well
as the negotiation and implementation of a personal AT
plan with the care recipient and his or her family care-
giver. Conception of the home-based ATPUT interven-
tion as a standardized approach to AT provision was
influenced by the work of Roelands, Van Oost, Stevens,
Depoorter, & Buysse [34] on the importance of shared
decision-making by caregivers and AT users living in the
community. It was developed in consultation with clini-
cians, AT users, and caregivers [29] and was found to be
safe, feasible, and relevant to the targeted individuals
when tested in a previous study [31]. It consists of 5 key
steps described in Table 1.
In contrast to current standards of care, the ATPUT
intervention will 1) follow a standardized multistep pro-
cedure that will be documented during each encounter
using a study-specific tool, 2) include additional in-
person follow-up visits that are not necessarily part of
customary care, 3) involve the AT user and family care-
giver collaboratively, and 4) provide AT and AT funding
in a timely manner, entailing financial assistance to re-
pair or acquire new AT, and training. In this regard, the
frequency and intensity of the experimental intervention
is expected to be greater than customary care. Partici-
pants will be allowed to pursue complimentary care dur-
ing the course of the ATPUT intervention. These will be
documented in the life changes form.
The intervention will be delivered by registered occu-
pational therapists trained by the research team to use
the same standardized approach and materials, based on
a treatment manual [31]. To avoid possible contamin-
ation, therapists who deliver the intervention to the ex-
perimental group will not treat members of the control
group.
Treatment fidelity
We will follow the NIH Behavior Change Consortium’s
recommendations [35] for enhancing treatment fidelity.
We address considerations of study design (intervention
is distinct, based on a conceptual framework), provider
training (occupational therapists will be trained on the
ATPUT through in-person or video-conferencing, and
will be using an intervention manual), treatment delivery
(reminder calls before each visit, home environment
where the skill is actually performed, treatment planning
by the occupational therapists), treatment receipt (check-
list of all intervention operations with dates performed),
and enactment of treatment (checks if the AT was ob-
tained and if necessary, installed; evaluation of the AT so-
lution during the final visit; adherence form to document
the degree of adherence to recommendations). Coordina-
tors will monitor checklists and review interventionist
data collection sheets for possible errors and coherence.
They will provide individual feedback regularly to occupa-
tional therapists and collect their notes, reflections and
comments.
Quantitative measurements
Table 2 highlights the measures to be administered at
each time point. Raters will administer all quantitative
measures. They will be trained by the study coordinator
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to ensure standardized administration of the measures.
The primary outcome measure for care recipients will
be a composite score from two sub-scales of the Func-
tional Autonomy Measurement System (SMAF) [36].
These sub-scales will include self-care and mobility, and
exclude the communication and mental functioning sub-
scales that are unlikely to be affected by the ATPUT
intervention. The SMAF will be administered to care re-
cipients and caregivers together, but all other outcome
measures will be administered to them separately. The
secondary outcomes will be the self-administered Func-
tional Independence Measure (FIM), a measure of self-
assessed independence in daily activities [37, 38], and
the Reintegration to Normal Living Index (RNLI), a
measure of social participation that address daily activ-
ities, roles and relationships [39, 40]. Finally, the SMAF
sub-scale relating to instrumental activities of daily living
will also be used as a secondary outcome.
Table 1 Steps in the Assistive Technology Provision Updating and Tune-Up Intervention
Step Objectives Intervention content
1. Identify and assess the problematic
activities with involvement of both the family
caregiver and recipient.
Agreement by the family caregiver and recipient
on the choice of problematic activities to be
targeted and features making them problematic.
Ascertain the difficulties related to
the problematic activities and strategies
currently used to deal with them.
Observe how the activity is currently
performed and determine the potential
for assistance.
Complete baseline assessment with tests
targeting the skills required to perform the
activity, if appropriate.
Determine what can be improved.
Explore possible strategies to address the
problematic activities.
Agreement among the family caregiver and
recipient on an AT-related strategy to addressed
the targeted problematic activities.
Discuss the family caregiver’s and older
adult’s current strategies related to ATs.
Describe the potential AT-related strategies
(from simple to more complex);
Discuss the advantages and disadvantages
of strategies related to ATs in general and
the targeted activity.
Discuss their preferences in ways of doing
things.
Explore relevant characteristics of the
physical and social environment of the dyad.
Inform family caregiver and recipient of the
skills required to use strategies related to ATs.
Provide information and/or demonstrate
candidate AT-related strategies (photos,
scenarios).
Give feedback in response to ideas/needs
expressed by the dyad.
Choose most appropriate ATs solutions. Agreement on the AT-related strategy to adopt. Summarize information collected in the
previous step.
Inform family caregiver and recipient about
relevant AT-related strategies available to them.
Arrive at an agreement about the AT-related
strategy to use
Take steps to implement the strategy.
Conduct training. Implementation of the AT-related strategy by the
dyad and competence in utilizing the relevant AT.
Demonstrate the implementation of the
AT-related strategy and use of the AT.
Practice with family caregiver and care
recipient.
Provide feedback.
Evaluate effectiveness of the AT-related
strategy.
Determine what additional intervention may be
called for and/or motivate family caregiver’ and
recipient’s to continue using the AT-related strategy.
Gauge the satisfaction of the family caregiver
and recipient with performing the targeted
activity and suggest remedies for problems
that are noted.
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The primary outcome measure for caregivers will be
the Caregiver AT Outcome Measure (CATOM) [31,
41]. Construction of the CATOM was based on a con-
ceptual framework of AT outcomes for AT users and
their caregivers [30]. The first part (items 1–14) classi-
fies specific activities for which the caregiver provides
support, and then measures the frequency of caregiving
and the perceived burden associated with the activities
(e.g., feeling physically tired after helping with the spe-
cified activities). The original CATOM was designed to
measure outcomes produced by AT interventions for a
single problematic activity, whereas the current study
will use a revised version that permits tracking the ef-
fects of AT interventions for multiple problematic ac-
tivities. In the original study, the internal consistency of
the activity-specific section of the CATOM was α = .73
[31]. The second part of the CATOM measures overall
burden and will be used as a secondary outcome meas-
ure. The overall burden section is comprised of four
items (15–18) measuring the caregiver’s degree of bur-
den associated with all of the assistance provided (e.g.,
feeling that caregiving duties limits recreational and
leisure activities). The internal consistency of this sec-
tion was α = .78 [31]. Other secondary outcomes for
caregivers will include hours of weekly care provided,
the Caregiver Burden Inventory (CBI) [42], and the
European Quality of Life (EQ-5D) visual analog system
and descriptive system [43]. The EQ-5D measures the
caregivers’ health status; the descriptive system is com-
prised of 5 items scored from 1 to 3, with higher total
scores indicating worse health. The CBI provides a
comparative measure of general caregiver burden
whereas the CATOM focuses on caregiving as it relates
to AT.
Socio-demographic and clinical data will be collected
about older adults’ age, sex, level of education, ethnic
origin, language, marital status, type of dwelling, diagno-
ses, duration of functional problems, and amount of
formal caregiving received, if applicable. For family care-
givers, collected data will include age, sex, level of edu-
cation, language, the relationship with the older adult
and cohabitation (yes/no), employment (yes/no), and
duration of assistance.
An adherence form and life changes form will be ad-
ministered respectively to capture the degree of adher-
ence to occupational therapist recommendations and
changing events in the lives of dyad members that could
affect outcome measures. Older adults’ and family care-
givers’ versions will be administered separately. The life
changes form will also capture any adverse events that
occur. A chart review of the occupational therapist notes
for each dyad will summarize the reasons for referral,
the number of visits, the AT provided, and the goals of
each session. This review will be conducted after the in-
terventions (customary or experimental) are completed,
i.e., six weeks or more following baseline assessment. A
therapist survey will also be completed by participating
occupational therapists to collect data about their level
of education, years of practice, and years of experience
working in this area.
Table 2 Quantitative measures and assessments collected at baseline, week 6, week 22 and week 58
Measures Tools/Metrics Baseline 6 weeks 22 weeks 58 weeks
Primary outcomes for AT users SMAF sub-scales, self-care & mobility X X X X




X X X X
Primary outcomes for family caregivers CATOM
(items 1–14)
X X X X
Secondary outcomes for family caregivers CATOM (items 15–18)
CBI
Hours of care
X X X X
Socio-demographic and clinical data for AT users MoCAa
Study-specific questionnaire
X
Socio-demographic and clinical data for family caregivers Study-specific questionnaire X X X X





Abbreviations: CATOM Caregiver Assistive Technology Outcome Measurement, CBI Caregiver Burden Inventory, EQ-5D European Quality of Life, FIM Functional
Independence Measure, IADL Instrumental activity of daily living, MoCA Montreal Cognitive Assessment, RNLI Reintegration to Normal Living Index, SMAF
Functional Autonomy Measurement System
aMoCA is only re-administered at T1, T2, and T3 if major changes are observed by the raters
bChart reviews and therapist surveys are done at 6 weeks or later
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Quantitative sample size
Sample size was calculated for the primary endpoint
(22 weeks) for older adults and family caregivers separ-
ately and the largest sample size was selected. The sam-
ple size for the primary caregiver outcome measure
(CATOM) was chosen to detect a 10 % decrease in per-
ceived burden. This is consistent with the caregiver
burden change noted in a prior trial using CATOM
scores at baseline and after 16 weeks [31]. It indicates a
one-level decrease on half of the items for the family
caregivers (nearly always→ frequently→ sometimes→
rarely→ not at all). The primary older adults’ outcome
measure is the SMAF. The sample size was chosen in
order to detect an improvement of 9 % following the
intervention. This value is intermediate between the
minimal detectable difference and the change measured
by administering the SMAF in a study examining the
impact of a rehabilitation program on individuals with
post-cerebral vascular accident [44, 45].
To determine an effect size, Cohen’s D was calculated
using standard deviations from our prior study [31] and
then transformed into Cohen’s F [46, 47]. As the effect
size was smaller for the SMAF, we used this value to
simulate various potential scenarios using G*Power
3.1.0.87. For these simulations we varied several vari-
ables including 1) effect size (0.13 to 0.15), 2) correla-
tions among repeated measures (which previous data
suggest will be moderate for pre-post intervention and
strong between post intervention and long term follow
up, e.g. 0.5 to 0.6), and 3) violations of sphericity (due to
differences in variances over time, e.g., 0.6 to 0.9). The
average of these sample sizes is 102. Based on approxi-
mately a 20 % dropout rate for the main trial endpoint
(suggested by the prior study in which dropout occurred
exclusively due to health related issues, which are com-
mon in this population), a sample of 120 dyads will be
recruited (40 from each site).
Quantitative data analysis of primary and secondary
outcome measures
Data will be entered by raters into SPSS statistics data
editor (IBM SPSS Statistics) immediately after each
evaluation session to decrease the likelihood of missing
data. The use of multiple imputation will be explored to
deal with any missing data, especially if a participant is
unable to be assessed at one of the data collection time-
points [48].
To ensure baseline similarity between groups, the ex-
perimental and control groups will be compared on
socio-demographic and clinical variables with the use of
t-tests for continuous data and Chi-square for nominal
data. Descriptive statistics and histograms will be used
to display differences between the groups. A repeated
measures analysis of variance will be conducted to
analyze dependent variable data, using a Greenhouse-
Geisser correction to address issues with sphericity.
Scores for the primary outcome measures (SMAF and
CATOM, items 1–14) will be compared between treat-
ment groups over time using an intention-to-treat
analysis. Intention-to-treat analysis dictates that all par-
ticipants are included in the group to which they were
allocated for purposes of analysis, whether or not they
completed the intervention for that group. The same
analysis will be applied to secondary outcome measures,
which include the RNLI, CATOM (items 15–18), CBI,
self-report FIM and hours of care provided by family
caregivers. These secondary outcome analyses will be
considered exploratory in view of the increased likeli-
hood of Type I errors resulting from multiple statistical
comparisons. Sensitivity analyses will be performed to
compare the effect of the interventions on 1) caregiving
spouses versus caregiving adult children, and 2) on par-
ticipants receiving services at the different sites.
To test for changes in family caregiver burden due to
the intervention, changes in older adults’ SMAF scores
will be correlated with changes in their caregivers’
CATOM scores, using either a Pearson or Spearman
correlation depending on the distribution of the data.
Quantitative data analysis for treatment fidelity
The percentage of intervention protocol items com-
pleted for each dyad in the experimental group will be
calculated to determine treatment fidelity. These data
will be supplemented with quantitative data retrieved
from the adherence form, life change forms and chart
reviews.
Quantitative data analysis for intervention information
For both groups, descriptive statistics will be used to
characterize therapists’ number, length, and total time of
visits; the number, types, and costs of devices; and occu-
pational therapists’ qualifications, years of practice, and
years of experience working in this area. Exploratory
post-hoc analysis will examine how these intervention
elements may have contributed to the various results
such as therapist differences, intensity of intervention,
delay in receipt of equipment, and types of devices
provided.
Participants for the qualitative study
To obtain variation within our interview sample [49],
participants will differ in terms of 1) type of family care-
givers, e.g., spouses or adult children; 2) older adults’
baseline functional autonomy levels (based on SMAF
scores); 3) type of AT provided; 4) research sites, and 5)
experimental versus control group membership. Based
on our previous research with this population and sug-
gested sample sizes for such research [50], we expect to
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conduct interviews with 20 to 25 dyads (40–50 individ-
ual interviews). As a sub-sample of the larger study,
interview participants will meet all of the inclusion cri-
teria for the quantitative study described above. As part
of the consent process, we will indicate that participants
in the subsample may be asked to take part in two add-
itional qualitative interviews.
Qualitative measures and data collection
To better understand how the intervention was adminis-
tered by therapists and experienced by older adults and
their family caregivers, three systematic qualitative
methods of data collection will be used. First, the regis-
tered occupational therapists providing the experimental
intervention will keep a record of the interventions that
they provide. The records will be reflective in nature and
describe a) the content of the treatment session, b) ele-
ments of the intervention that seem to be working well,
c) aspects that could be improved and d) general im-
pressions. Second, therapists from each site, regardless
of whether they administered care to the experimental
or control group, will be invited to be interviewed
individually to determine the process they used when
providing AT. Third, qualitative interviews will be con-
ducted with a purposeful selection of AT users and fam-
ily caregivers, to refine emerging interpretation of the
experience throughout the study. A member of the re-
search team who was not involved in data collection or
treatment administration will conduct these interviews.
They will be scheduled following quantitative data col-
lection at week 6 and at the end of the study.
Qualitative data analysis
Qualitative interviews will be digitally recorded and tran-
scribed verbatim. The transcripts will be reviewed while
listening to the audio file to ensure accuracy. Each inter-
view transcript and audio files will be labeled and stored
in qualitative data analysis software (NVivo10) according
to a) the participant’s pseudonym, b) the type of partici-
pant (occupational therapist, family caregiver or AT
user), c) the group type (control or experimental), and d)
its location (Montreal, Ottawa or Vancouver).
By repeatedly reviewing the data, we will develop ideas
and interpretations about recurring, converging and
contradictory patterns and will identify key concepts and
themes along with illustrative examples [51]. Broad cat-
egories will be developed to organize and inductively
code the raw data. Themes within and across partici-
pants are likely to emerge by means of this iterative
process [50]. Examples from the themes will be retrieved
and compared between and within field notes, partici-
pant observations, and interview transcripts. As the re-
view progresses, data will be coded and re-coded to
reflect emergent themes. “Negative cases” that do not fit
with the emergent themes will be explored to develop
tentative explanations for them. Ultimately, codes will be
grouped into relevant themes, and they will be organized
in a manner that is intended to promote understanding
of how the experimental and control interventions were
experienced.
Results from the treatment reflections and qualitative
interviews will be compared with the quantitative results
for older adults and their family caregivers to look for
divergent and complementary findings. The results for
each member of the dyad will be scrutinized separately,
as will data for the dyads comprising the experimental
group, especially when exploring interaction effects be-
tween older adults and family caregivers. Qualitative and
quantitative data will also be compared for individual
participants.
Given the previously demonstrated efficacy of AT in
earlier RCT interventions [9, 31, 52, 53], no data moni-
toring committee (DMC) will be used. The final qualita-
tive and quantitative trial dataset produced by the
intervention will be managed by and accessible to study
investigators, only. The dissemination of all findings and
analysis will be through academic articles authored by
the investigators that are published in refereed open ac-
cess journals. Participants who express interest will re-
ceive a lay summary of the findings of the study.
Discussion
As a society, we need all the empirical, methodological,
and theoretical knowledge available to respond ad-
equately to the problems faced by older adults, their
family caregivers, and service providers with respect to
the efficient use of assistive technology. This study will
be the first parallel-group RCT to examine an AT inter-
vention with emphasis on both the older adult with dis-
abilities and his/her family caregiver. Providing evidence
of the effectiveness of such an approach will encourage
service providers and clinicians to move forward with
AT recommendations that are more attuned to the
needs of both members of the dyad. It is important to
recognize the societal importance of responding to the
needs of family caregivers who in many instances may
be aging themselves. Resource limitations and social pol-
icies that promote aging in place also bolster the call for
an adequate response to family caregivers’ needs. Posi-
tive findings will highlight the value of an approach to
AT provision that is more inclusive of family caregivers
and will set the stage for econometric studies assessing
its cost-effectiveness.
The study is designed to evaluate the effectiveness of
an AT intervention in real-life conditions. As such, the
results are prone to be influenced by a host of factors in-
cluding older adults’ and family caregivers’ clinical and
socio-demographic characteristics, their home-related
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problematic activities, their home environment, the de-
vice types they are supplied, and the dynamics of the re-
lationship between them. This places a premium on
having sufficient power to control for the concomitant
effects of those factors. However, this study has the ad-
vantage of being built on the results of a previous one,
which did detect a clinically significant effect of the
ATPUT intervention [31]. Moving from that study to
this planned, parallel-group RCT is a logical step toward
the next best evidence. The results from the planned
study should be transferable and usable in real life.
Our design combines qualitative and quantitative
methods and measures. Given the limited research on
the relationship between caregiver burden and AT, the
qualitative data will extend our knowledge in this area
beyond the results of the quantitative portion of the re-
search and will allow exploration of possible feelings of
ambivalence toward assistive devices that have been
reported in previous studies [54, 55]. The proposed re-
search approach may serve to highlight ways of improv-
ing the way AT and AT education is provided in the
community, and may suggest a model for assessing the
effectiveness of other AT interventions. It may also ad-
vance the methodology of studying AT outcomes for AT
users and caregivers.
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